AstraZeneca Pharma India Limited (BOM:506820)
India
· Delayed Price · Currency is INR 8,457.85
-118.25 (-1.38%)
At close: Apr 28, 2026
AstraZeneca Pharma India Employees
AstraZeneca Pharma India had 802 employees as of March 31, 2025. The number of employees decreased by 138 or -14.68% compared to the previous year.
Employees
802
Change (1Y)
-138
Growth (1Y)
-14.68%
Revenue / Employee
36.29M INR
Profits / Employee
3.35M INR
Market Cap
211.45B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Granules India | 4,066 |
| Jubilant Pharmova | 5,547 |
| J. B. Chemicals & Pharmaceuticals | 5,304 |
| Caplin Point Laboratories | 3,966 |
| GlaxoSmithKline Pharmaceuticals | 3,113 |
| CORONA Remedies | 4,500 |
| Viyash Scientific | 1,244 |
| Procter & Gamble Health | 1,326 |
AstraZeneca Pharma India News
- 18 days ago - AstraZeneca Pharma India secures approval to market Calquence for new indication - Business Upturn
- 21 days ago - AstraZeneca, Telangana govt to roll out AI-powered lung cancer screening in public hospitals - The Times of India
- 4 weeks ago - AstraZeneca Pharma India appoints Dr. Shashank Srinivasan and promotes Mr. Venkat Natarajan - Business Upturn
- 5 weeks ago - AstraZeneca Pharma India announces resignation of non-executive director Jesús Diaz-Ropero Esteso - Business Upturn
- 6 weeks ago - AstraZeneca Pharma India receives approval to market Imfinzi for unresectable hepatocellular carcinoma - Business Upturn
- 2 months ago - ASTRAZEN shares fall over 4% as Q3 EBITDA drops 41.8% YoY to Rs 44.8 crore - Business Upturn
- 2 months ago - Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment - NDTV
- 4 months ago - AstraZeneca Pharma India receives CDSCO approval to import and market Datverzo in India - Business Upturn